基础研究

孟鲁司特钠通过PHD2/HIF-1α通路抑制哮喘小鼠气道炎症反应

  • 孔春雪 ,
  • 刘其器 ,
  • 张立伟 ,
  • 吴传莎 ,
  • 熊龙珠 ,
  • 张国薇 ,
  • 曹敏越 ,
  • 李平 ,
  • 周婷
展开
  • 1.武汉科技大学医学部公共卫生学院,职业危害识别与控制湖北省重点实验室,环境毒理学研究室 (湖北 武汉 430065 )
    2.湖北医药学院附属襄阳市第一人民医院呼吸与危重医学科 (湖北 襄阳 441000 )

收稿日期: 2024-11-04

  网络出版日期: 2025-03-20

基金资助

国家自然科学基金青年项目(42407584);武汉科技大学研究生创新创业基金项目(JCX2023120)

Montelukast sodium inhibits airway inflammation through Phd2/Hif⁃1Α pathway in asthmatic mice

  • Chunxue KONG ,
  • Qiqi LIU ,
  • Liwei ZHANG ,
  • Chuansha WU ,
  • Longzhu XIONG ,
  • Guowei ZHANG ,
  • Minyue CAO ,
  • Ping LI ,
  • Ting ZHOU
Expand
  • *.Environmental Toxicology Laboratory,Hubei Province Key Laboratory of Occupational Hazard Identification and Control,School of Public Health,Department of Medicine,Wuhan University of Science and Technology,Wuhan 430065,China

Received date: 2024-11-04

  Online published: 2025-03-20

摘要

目的 探究孟鲁司特钠是否能通过影响PHD2/HIF-1α通路缓解哮喘小鼠气道炎症反应。 方法 通过卵清蛋白(OVA)诱导建立过敏性哮喘模型,将18只BALB/c雌性小鼠随机分为对照组(Con组)、哮喘组(OVA组)、孟鲁司特钠干预哮喘组(在OVA激发前1 h经口灌胃30 mg/kg孟鲁司特钠,Mon组)。HE染色检测小鼠肺部病理改变,血球分析仪和试剂盒测定肺部炎症细胞数量及细胞因子、乳酸和丙酮酸含量,RT-PCR和Western blot检测小鼠肺缺氧诱导因子-1α(HIF-1α)、脯氨酸羟化酶2(PHD2)、E-黏钙蛋白(E-cad)和p120 mRNA和蛋白表达量。 结果 与对照组比较,OVA组小鼠肺部嗜酸性粒细胞、淋巴细胞、中性粒细胞和单核细胞数量增多,白细胞介素-5(IL-5)、白细胞介素-13(IL-13)、补体因子D(CFD)及乳酸、丙酮酸的含量都显著升高,肺HIF-1α、PHD2、p120和E-cad的mRNA水平降低,而HIF-1α和PHD2蛋白表达上调,E-cad和p120蛋白表达下调(均P < 0.05),经孟鲁司特钠干预的Mon组小鼠肺部嗜酸性和单核细胞数量及CFD含量显著下降,乳酸和丙酮酸的含量基本恢复至正常,HIF-1α、PHD2、p120和E-cad的mRNA及蛋白表达量均得到有效改善。 结论 孟鲁司特钠可能通过调控PHD2/HIF-1α信号通路缓解过敏性哮喘小鼠肺部气道炎症反应。

本文引用格式

孔春雪 , 刘其器 , 张立伟 , 吴传莎 , 熊龙珠 , 张国薇 , 曹敏越 , 李平 , 周婷 . 孟鲁司特钠通过PHD2/HIF-1α通路抑制哮喘小鼠气道炎症反应[J]. 实用医学杂志, 2025 , 41(5) : 664 -669 . DOI: 10.3969/j.issn.1006-5725.2025.05.007

Abstract

Objective The study aimed to investigate whether montelukast sodium could alleviate airway inflammatory responses in asthmatic mice by affecting the PHD2/HIF?1α pathway. Methods An allergic asthma model was established by ovalbumin (OVA) induction, and 18 female BALB/c mice were randomly divided into a control group (Con group), an asthma group (OVA group), and an asthma group with montelukast sodium intervention (30 mg/kg montelukast sodium by oral administration 1 h before OVA challenge, Mon group). HE staining was used to analyze the pathological changes in the lungs of mice. Blood cell analyzer and kits were used to determine the number of inflammatory cells and the levels of cytokines, the content of lactic acid and pyruvic acid in the lungs, respectively. RT?PCR and Western blot were used to detect the mRNA and protein expression of HIF?1α, PHD2, E?cad and p120 in the lungs of mice. Results Compared with the Con group, there was a significant increase in the number of eosinophils, lymphocytes, neutrophils and monocytes, the levels of IL?5, IL?13, complement factor D (CFD) and contents of lactate and pyruvate in the lungs of mice in the OVA group. Lung HIF?1α, PHD2, p120 and E?cad mRNA levels were reduced, meanwhile HIF?1α and PHD2 protein expression were upregulated but E?cad and p120 protein expression were downregulated (all with P < 0.05). After montelukast sodium intervention, the number of eosinophils and monocytes and CFD expression were significantly decreased in the lungs of Mon group, the contents of lactate and pyruvate were basically restored to normal, and the mRNA and protein expression of HIF?1α, PHD2, p120 and E?cad were effectively improved. Conclusion Montelukast sodium could alleviate the airway inflammatory responses in the lungs of asthmatic mice by regulating the PHD2/ HIF?1α signaling pathway.

参考文献

1 GANS M D, GAVRILOVA T. Understanding the immunology of asthma: Pathophysiology, biomarkers, and treatments for asthma endotypes[J]. Paediatr Respir Rev, 2020, 36: 118-127. doi:10.1016/j.prrv.2019.08.002
2 何贵强, 郎艳竹, 赵顺顺, 等. 白细胞介素-22在哮喘气道重塑中的作用研究进展[J]. 实用医学杂志, 2022, 38(19): 2491-2494,2500.
3 GARNER O, RAMEY J S, HANANIA N A. Management of Life-Threatening Asthma: Severe Asthma Series[J]. Chest, 2022, 162(4): 747-756. doi:10.1016/j.chest.2022.02.029
4 冯日昇, 郭燕军. 孟鲁司特钠联合维生素D治疗婴幼儿喘息的疗效及对肺功能和细胞因子的影响[J]. 实用医学杂志, 2019, 35(3): 456-460.
5 AL-AZZAM N, ELSALEM L. Leukotriene D(4) role in allergic asthma pathogenesis from cellular and therapeutic perspectives[J]. Life Sci, 2020, 260: 118452. doi:10.1016/j.lfs.2020.118452
6 吴华. 白三烯及其受体拮抗剂在肺部疾病中作用的研究进展[J]. 中华妇幼临床医学杂志(电子版), 2017, 13(2): 234-239.
7 WERMUTH H R, BADRI T, TAKOV V. Montelukast [M]. StatPearls. Treasure Island (FL) ineligible companies. Disclosure: Talel Badri declares no relevant financial relationships with ineligible companies. Disclosure: Veronica Takov declares no relevant financial relationships with ineligible companies.; StatPearls Publishing Copyright ? 2024, Stat Pearls Publishing LLC. 2024.
8 CASAS A, GóMEZ F P, DAHLéN B, et al. Leukotriene D4-induced hypoxaemia in asthma is mediated by the cys-leukotriene1 receptor[J]. Eur Respir J, 2005, 26(3): 442-448. doi:10.1183/09031936.05.00147504
9 HUERTA-YEPEZ S, BAAY-GUZMAN G J, BEBENEK I G, et al. Hypoxia inducible factor promotes murine allergic airway inflammation and is increased in asthma and rhinitis[J]. Allergy, 2011, 66(7): 909-918. doi:10.1111/j.1398-9995.2011.02594.x
10 MA Y, QIU S, ZHOU R. Osteoporosis in Patients With Respiratory Diseases[J]. Front Physiol, 2022, 13: 939253. doi:10.3389/fphys.2022.939253
11 SHUKLA S D, WALTERS E H, SIMPSON J L, et al. Hypoxia-inducible factor and bacterial infections in chronic obstructive pulmonary disease[J]. Respirology, 2020, 25(1): 53-63. doi:10.1111/resp.13722
12 BAEK K J, CHO J Y, ROSENTHAL P, et al. Hypoxia potentiates allergen induction of HIF-1α, chemokines, airway inflammation, TGF-β1, and airway remodeling in a mouse model[J]. Clin Immunol, 2013, 147(1): 27-37. doi:10.1016/j.clim.2013.02.004
13 ADLURI R S, THIRUNAVUKKARASU M, DUNNA N R, et al. Disruption of hypoxia-inducible transcription factor-prolyl hydroxylase domain-1 (PHD-1-/-) attenuates ex vivo myocardial ischemia/reperfusion injury through hypoxia-inducible factor-1α transcription factor and its target genes in mice[J]. Antioxid Redox Signal, 2011, 15(7): 1789-1797. doi:10.1089/ars.2010.3769
14 CUI J, XU F, TANG Z, et al. Bu-Shen-Yi-Qi formula ameliorates airway remodeling in murine chronic asthma by modulating airway inflammation and oxidative stress in the lung[J]. Biomed Pharmacother, 2019, 112: 108694. doi:10.1016/j.biopha.2019.108694
15 CHEN X, KANG Y B, WANG L Q, et al. Addition to inhaled corticosteroids of leukotriene receptor antagonists versus theophylline for symptomatic asthma: A meta-analysis[J]. J Thorac Dis, 2015, 7(4): 644-652.
16 孙晓丽, 张湘华, 曹晓玮. 孟鲁司特钠片联合布地奈德混悬液治疗支气管哮喘的效果及对患者气道炎症反应的影响[J]. 中国医药, 2020, 15(11): 1693-1696.
17 HUANG Y N, XU Y Y, MA Q, et al. Dextran Sulfate Effects EMT of Human Gastric Cancer Cells by Reducing HIF-1α/ TGF-β[J]. J Cancer, 2021, 12(11): 3367-3377. doi:10.7150/jca.55550
18 LU Y, JI N, WEI W, et al. MiR-142 modulates human pancreatic cancer proliferation and invasion by targeting hypoxia-inducible factor 1 (HIF-1α) in the tumor microenvironments[J]. Biol Open, 2017, 6(2): 252-259. doi:10.1242/bio.021774
19 CHENG Q, SHANG Y. ORMDL3 may participate in the pathogenesis of bronchial epithelial?mesenchymal transition in asthmatic mice with airway remodeling[J]. Mol Med Rep, 2018, 17(1): 995-1005.
20 吴启北, 房震, 陈刚, 等. 孟鲁司特钠治疗慢性阻塞性肺疾病急性加重期患者的疗效及对NLR、EOS及RDW的影响[J]. 分子诊断与治疗杂志, 2023, 15(8): 1339-1343.
21 牛莉娜, 郭素娟, 牛丽鑫, 等. 孟鲁司特钠治疗儿童咳嗽变异性哮喘效果的临床观察[J]. 临床肺科杂志, 2015, 20(6): 1073-1075.
22 TRINH H K T, SUH D H, NGUYEN T V T, et al. Characterization of cysteinyl leukotriene-related receptors and their interactions in a mouse model of asthma[J]. Prostaglandins Leukot Essent Fatty Acids, 2019, 141: 17-23. doi:10.1016/j.plefa.2018.12.002
23 LYNCH K R, O'NEILL G P, LIU Q, et al. Characterization of the human cysteinyl leukotriene CysLT1 receptor[J]. Nature, 1999, 399(6738): 789-793. doi:10.1038/21658
24 ICHIYAMA T, HASEGAWA M, UENO Y, et al. Cysteinyl leukotrienes induce monocyte chemoattractant protein 1 in human monocytes/macrophages[J]. Clin Exp Allergy, 2005, 35(9): 1214-1219. doi:10.1111/j.1365-2222.2005.02323.x
25 BARRATT J, WEITZ I. Complement Factor D as a Strategic Target for Regulating the Alternative Complement Pathway[J]. Front Immunol, 2021, 12: 712572. doi:10.3389/fimmu.2021.712572
26 李军委, 张霞, 苏颖. 孟鲁司特钠片联合沙美特罗替卡松粉对哮喘-慢性阻塞性肺疾病重叠综合征患者炎症反应及气道重塑的影响[J]. 临床医学研究与实践, 2024, 9(9): 63-67.
27 NOLT B, TU F, WANG X, et al. Lactate and Immunosuppression in Sepsis[J]. Shock, 2018, 49(2): 120-125. doi:10.1097/shk.0000000000000958
28 赵丽, 李杰. 生命的低氧适应——2019年度诺贝尔生理学或医学奖成果解析[J]. 科技导报, 2020, 38(2): 79-85.
29 李健维, 谢宗玉. HIF-1α及其相关通路在缺氧缺血性脑病中的研究进展[J]. 蚌埠医学院学报, 2021, 46(5): 695-699.
30 LUO Z, ZENG W, DU G, et al. Enhancement of pyruvic acid production in Candida glabrata by engineering hypoxia-inducible factor 1[J]. Bioresour Technol, 2020, 295: 122248. doi:10.1016/j.biortech.2019.122248
31 TRINH H K T, PHAM D L, CHOI Y, et al. Epithelial folliculin enhances airway inflammation in aspirin-exacerbated respiratory disease[J]. Clin Exp Allergy, 2018, 48(11): 1464-1473. doi:10.1111/cea.13253
32 ISHIYAMA N, LEE S H, LIU S, et al. Dynamic and static interactions between p120 catenin and E-cadherin regulate the stability of cell-cell adhesion[J]. Cell, 2010, 141(1): 117-128. doi:10.1016/j.cell.2010.01.017
33 隋翔宇, 张相春, 张光永, 等. 连环蛋白p120在炎性肺损伤中保护作用的初步研究[J]. 山东大学学报(医学版), 2014, 53(12): 41-44,49.
34 LAMOUILLE S, XU J, DERYNCK R. Molecular mechanisms of epithelial-mesenchymal transition[J]. Nat Rev Mol Cell Biol, 2014, 15(3): 178-196. doi:10.1038/nrm3758
35 ZHAO J, ZHANG H, LIU Y, et al. HIF-1α knockdown suppresses breast cancer metastasis via epithelial mesenchymal transition Abrogation[J]. Heliyon, 2024, 10(19): e37900. doi:10.1016/j.heliyon.2024.e37900
文章导航

/